Patients on a Fixed Dose of DOAC: What Percentage is in the Therapeutic Window?

Hendrick Coenraad Hemker; Saartje Bloemen; Romy Kremers; H. Kelchtermans; Jonathan Douxfils; François Mullier; Bas de Laat

Patients on a Fixed Dose of DOAC: What Percentage is in the Therapeutic Window?

Hendrick Coenraad Hemker, Saartje Bloemen, Romy Kremers, H. Kelchtermans, Jonathan Douxfils, François Mullier, Bas de Laat

Research output: Contribution to conference › Poster › peer-review

Original language	English
Publication status	Published - 2017
Event	XXVI Congress of the International Society on Thrombosis and Haemostasis - Berlin, Germany Duration: 8 Jul 2017 → 13 Jul 2017

Conference

Conference	XXVI Congress of the International Society on Thrombosis and Haemostasis
Country/Territory	Germany
City	Berlin
Period	8/07/17 → 13/07/17

Cite this

@conference{ffed71481bdb40f69f9b3ad8a2e2ba0b,

title = "Patients on a Fixed Dose of DOAC: What Percentage is in the Therapeutic Window?",

author = "Hemker, \{Hendrick Coenraad\} and Saartje Bloemen and Romy Kremers and H. Kelchtermans and Jonathan Douxfils and Fran{\c c}ois Mullier and \{de Laat\}, Bas",

year = "2017",

language = "English",

note = "XXVI Congress of the International Society on Thrombosis and Haemostasis ; Conference date: 08-07-2017 Through 13-07-2017",

}